AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

Core Viewpoint - Amgen will present at Citi's 2026 Virtual Oncology Leadership Summit on February 18, 2026, highlighting its ongoing commitment to oncology and innovative medicine development [1] Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines targeting serious diseases [1] - The company has been a pioneer in the biotechnology industry for over 45 years, based in Thousand Oaks, California [1] - Amgen's portfolio includes treatments for cancer, heart disease, inflammatory conditions, rare diseases, and obesity-related conditions [1] Presentation Details - Jean-Charles Soria, senior vice president of oncology at Amgen, will lead the presentation at the summit [1] - The webcast will be available to the media, investors, and the public, and will be archived for at least 90 days post-event [1] Recognition and Market Position - Amgen is recognized for its innovation and workplace culture, receiving accolades from Fast Company and Forbes [1] - The company is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, indicating its significant market capitalization and innovation in the non-financial sector [1]